EuroIntervention | Your reference journal for coronary, valvular and structural interventions

Your reference journal for coronary, valvular and structural interventions

Podcast

Apr 2

Editor's Choice is EuroIntervention's latest podcast series, bringing you key highlights of selected recently published studies. Listen in twice monthly as the authors themselves discuss their work with host Aysha Cader. Episode 1 with Tobias Geisler and Mia Ravn Jacobsen is out now - with more episodes to come!

Flashlight

Apr 1

3D ICE-guided TTVR

Srivatsan Swaminathan, Gilbert H.L. Tang, et al.

A 73-year-old female with a history of rheumatic fever and severe mitral stenosis who had undergone TMVR presented with severe tricuspid regurgitation. 3D ICE-guided TTVR was performed, with a successful outcome.

CONSENSUS DOCUMENT

Mar 31

DAPT for secondary prevention in patients with ACS

This consensus provides practical guidance on personalizing dual antiplatelet therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention to optimize clinical outcomes by balancing ischemic and bleeding risks.

open access

Trial Design

Mar 30

mViV vs rMVR for BVD: the SURVIV trial

Dimytri A. Siqueira, Fausto Feres, et al.

The SURVIV trial is a randomized study comparing transcatheter mitral valve-in-valve and surgical redo-mitral valve replacement in patients with failed bioprosthetic mitral valves.

Research Correspondence

Mar 27

Extended-length introducer sheaths for TAVI

Yusuke Kobari, Ole De Backer, et al.

The study found that the use of an extended-length sheath during transfemoral transcatheter aortic valve implantation (TF-TAVI) in patients with a hostile aortic anatomy is feasible and may enhance procedural safety by potentially avoiding vascular and/or calcific/thromboembolic complications.

Extended-length introducer sheaths for TAVI

Editorial

Mar 25

An aortic valve FFR?

Morton J. Kern, Derek Antoku

The editorial discusses the potential use of transvalvular hemodynamics, such as the stress aortic valve index (SAVI), to help guide decision-making around the need for aortic valve replacement in patients with moderate or mild aortic stenosis.

free

Original Research

Mar 23

The SAVI-AoS trial

Rob Eerdekens, Pim A.L. Tonino, et al.

This study evaluated symptomatic patients with moderate aortic stenosis and preserved ejection fraction using invasive and non-invasive assessments at rest and during stress. The stress aortic valve index strongly predicted the need for aortic valve intervention.

Turning Point Podcast

Listen now

Flashlight

Mar 20

Leaflet avulsion after UNICORN

Arif A. Khokhar, Ole De Backer, et al.

The content discusses the UNICORN technique for reducing the risk of coronary obstruction during redo-TAVI, highlighting the need for caution due to the unpredictable nature of complete leaflet avulsion and the potential benefits of orthotopic coronary wiring and stenting.

State-of-the-Art

Mar 18

TAVI thrombosis

Mia Ravn Jacobsen, Tobias Geisler, et al.

This review examines the prevalence, mechanisms, and management of leaflet thrombosis after transcatheter aortic valve implantation (TAVI), a minimally invasive procedure for severe aortic stenosis.

free

new issue

Mar 16

A new issue of EuroIntervention

A State-of-the-Art on TAVI thrombosis; a novel stress aortic valve index; design and rationale of the SURVIV trial; extended-length introducer sheaths for TAVI; leaflet avulsion after UNICORN leaflet modification; 3D intracardiac echo-guided transcatheter tricuspid valve replacement; and more

Original Research

Mar 13

CLTI outcomes with drug-coated devices

Maxime Dubosq-Lebaz, Eric A. Secemsky, et al.

In a national cohort of Medicare beneficiaries with chronic limb-threatening ischemia, drug-coated devices were associated with reduced amputation, mortality, and reintervention compared to uncoated devices, without increased costs.

free

Editorial

Mar 13

Drug-coated devices in CLTI revascularisation

Piotr Musiałek, Antonio Micari

A registry study comparing endovascular treatment options for peripheral artery disease in the femoropopliteal segment found a statistically significant benefit of drug-coated/drug-eluting devices in reducing major amputation/death and major adverse limb events.

free

Editorial

Mar 12

Validating experimental evidence through practice

Javier Escaned, Guus de Waard

The study examined the relationship between coronary flow, stenosis severity, and microvascular resistance, confirming previous experimental observations and providing insights based on in-vivo measurements in a large patient cohort.

Validating experimental evidence through practice

free

Original Research

Mar 11

Absolute coronary flow after PCI

Federico Marin, Giovanni Luigi De Maria, et al.

This study found that percutaneous coronary intervention (PCI) significantly reduces epicardial resistance, leading to a pronounced increase in hyperaemic flow, which can be predicted by fractional flow reserve (FFR). Resting flow remained unchanged due to compensatory increases in microvascular resistance.